Your browser doesn't support javascript.
loading
Inhibition of abnormal C/EBPß/α-Syn signaling pathway through activation of Nrf2 ameliorates Parkinson's disease-like pathology.
Lin, Zefang; Huang, Lixuan; Cao, Qianqian; Luo, Hanyue; Yao, Wei; Zhang, Ji-Chun.
Affiliation
  • Lin Z; Department of Physiology, School of Medicine, Jinan University, Guangzhou, China.
  • Huang L; Department of Physiology, School of Medicine, Jinan University, Guangzhou, China.
  • Cao Q; Department of Physiology, School of Medicine, Jinan University, Guangzhou, China.
  • Luo H; Department of Physiology, School of Medicine, Jinan University, Guangzhou, China.
  • Yao W; Guangzhou Key Laboratory of Formula-pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
  • Zhang JC; Department of Physiology, School of Medicine, Jinan University, Guangzhou, China.
Aging Cell ; 22(10): e13958, 2023 10.
Article in En | MEDLINE | ID: mdl-37614147

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Neuroblastoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Aging Cell Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Neuroblastoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Aging Cell Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom